The Wegovy pill is now available. Wegovy pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight. Wegovy pill is available to all eligible patients with multiple affordability options. Self-pay patients can start at around $5/day, $149/month, for the starting dose of 1.5 mg. The 4 mg dose will also be available for $149/month through April 15, 2026, then $199/month after, and the highest doses of Wegovy pill will be available for $299. Commercially insured patients pay as low as $25/month with the Wegovy savings offer.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo to launch Wegovy in U.S. starting from $149 per month, Reuters says
- Novo Nordisk Stock Jumps as it Battles Eli Lilly for Market Share with $149 Wegovy Pill Launch
- Moderately bullish activity in Novo Nordisk with shares up 2.31%
- Pfizer (PFE) Tops List as Drugmakers Plan Price Hike on 350 Medications
- Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal